Immediate Impact
1 from Science/Nature 84 standout
Citing Papers
Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials
2024 Standout
Allergic Rhinitis
2024 Standout
Works of Mark H. Moss being referenced
Short-Term Subcutaneous Allergy Immunotherapy and Dupilumab are Well Tolerated in Allergic Rhinitis: A Randomized Trial
2021
Omalizumab pretreatment prevents allergic reactions due to rush immunotherapy (RIT)
2005
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Mark H. Moss | 1294 | 1126 | 188 | 24 | 1.4k | |
| E. Helen Ramsdale | 1556 | 1410 | 351 | 24 | 1.9k | |
| M.R. Sears | 1708 | 1263 | 407 | 13 | 2.0k | |
| Michael Mellon | 1395 | 1093 | 499 | 27 | 2.0k | |
| Mona Palmqvist | 1604 | 1386 | 415 | 35 | 1.9k | |
| Stephen J. Langley | 1502 | 1289 | 326 | 28 | 1.9k | |
| Jonathan Matz | 1375 | 1069 | 612 | 17 | 1.5k | |
| Carin Jorup | 1785 | 1701 | 197 | 30 | 2.0k | |
| Marzena Krawiec | 1535 | 1394 | 242 | 23 | 1.8k | |
| Luz A. Froehlich | 971 | 855 | 350 | 16 | 1.5k | |
| Christina Keen | 914 | 878 | 122 | 25 | 1.2k |
All Works
Loading papers...